[1] Furuse M,Nonoguchi N,Yamada K,et al.Radiological diagnosis of brain radiation necrosis after cranial irradiation for brain tumor:a systematic review[J].Radiat Oncol,2019,14(1):28.
[2] Wu EL,Patel A,McGunigal MC,et al.Characterization of cerebral radiation necrosis following the treatment of sinonasal malignancies[J].Laryngoscope Investig Otolaryngol,2024,9(2):e1200.
[3] Choi M,Zabramski JM.Re-irradiation using brachytherapy for recurrent Intracranial tumors:a asystematic review and meta-analysis of the literature[J].Cureus,2020,12(8):e9666.
[4] Vellayappan B,Tan CL,Yong C,et al.Diagnosis and management of radiation necrosis in patients with brain metastases[J].Front Oncol,2018,8:395.
[5] Hong CS,Beckta JM,Kundishora AJ,et al.Laser interstitial thermal therapy for treatment of cerebral radiation necrosis[J].Int J Hyperthermia,2020,37(2):68~76.
[6] Chin LS,Ma L,DiBiase S.Radiation necrosis following gamma knife surgery:a case-controlled comparison of treatment parameters and long-term clinical follow up[J].J Neurosurg,2001,94(6):899~904.
[7] Zhuang HQ,Zheng Y,Wang JJ,et al.Analysis of risk and predictors of brain radiation necrosis after radiosurgery[J].Oncotarget,2016,7(7):7773~7779.
[8] 杨军,李玉侠,张梦,等.脑转移瘤放疗后放射性脑坏死的风险因素[J].江西医药,2022,57(12):2048~2051.
[9] Blonigen BJ,Steinmetz RD,Levin L,et al.Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery[J].Int J Radiat Oncol Biol Phys,2010,77(4):996~1001.
[10] 陈意,王鑫,孙冰,等.抗血管药物治疗放射性脑坏死专家共识[J].中国肺癌杂志,2022,25(5):291~294.
[11] Korytko T,Radivoyevitch T,Colussi V,et al.12 Gy gamma knife radiosurgical volume is a predictor for radiation necrosis in non-AVM intracranial tumors[J].Int J Radiat Oncol Biol Phys,2006,64(2):419~424.
[12] Li J,He J,Cai LB,et al.Bevacizumab as a treatment for radiation necrosis following stereotactic radiosurgery for brain metastases:clinical and radiation dosimetric impacts[J].Ann Palliat Med,2021,10(2):2018~2026.
[13] Kim JM,Miller JA,Kotecha R,et al.The risk of radiation necrosis following stereotactic radiosurgery with concurrent systemic therapies[J].J Neurooncol,2017,133(2):357~368.
[14] Miller JA,Bennett EE,Xiao R,et al.Association between radiation necrosis and tumor biology after stereotactic radiosurgery for brain metastasis[J].Int J Radiat Oncol Biol Phys,2016,96(5):1060~1069.
[15] Wang TM,Shen GP,Chen MY,et al.Genome-wide association study of susceptibility loci for radiation-induced brain injury[J].J Natl Cancer Inst,2019,111(6):620~628.
[16] Patel KR,Chowdhary M,Switchenko JM,et al.BRAF inhibitor and stereotactic radiosurgery is associated with an increased risk of radiation necrosis[J].Melanoma Res,2016,26(4):387~394.
[17] Zhuang HQ,Tao LY,Wang X,et al.Tyrosine kinase inhibitor resistance increased the risk of cerebral radiation necrosis after stereotactic radiosurgery in brain metastases of non-small-cell lung cancer:amulti-institutional retrospective case-control study[J].Front Oncol,2020,10:12.
[18] Todnem N,Ward A,Nahhas M,et al.A retrospective cohort analysis of hemorrhagic arteriovenous malformations treated with combined endovascular embolization and gamma knife stereotactic radiosurgery[J].World Neurosurg,2019,122:e713~e722.
[19] Barillaro A,Caroprese M,Cella L,et al.Stereotactic radiation therapy for brain metastases:factors affecting outcomes and radiation necrosis[J].Cancers (Basel),2023,15(7):2094.
[20] Zhuang H,Shi S,Yuan Z,et al.Bevacizumab treatment for radiation brain necrosis:mechanism,efficacy and issues[J].Mol Cancer,2019,18(1):21.
[21] Kwon HS,Koh SH.Neuroinflammation in neurodegenerative disorders:the roles of microglia and astrocytes[J].Transl Neurodegener,2020,9(1):42.
[22] Sneed PK,Mendez J,Vemer-van den Hoek JG,et al.Adverse radiation effect after stereotactic radiosurgery for brain metastases:incidence,time course,and risk factors[J].J Neurosurg,2015,123(2):373~386.
[23] Miyatake S,Nonoguchi N,Furuse M,et al.Pathophysiology,diagnosis,and treatment of radiation necrosis in the brain[J].Neurol Med Chir (Tokyo),2015,55 (1):50~59.
[24] Chuang MT,Liu YS,Tsai YS,et al.Differentiating radiation-induced necrosis from recurrent brain tumor using MR perfusion and spectroscopy:A meta-analysis[J].PLoS One,2016,11(1):e0141438.
[25] Yekula A,Muralidharan K,Rosh ZS,et al.Liquid biopsy strategies to distinguish progression from pseudoprogression and radiation necrosis in glioblastomas[J].Adv Biosyst,2020,4(12):e2000029.
[26] Furuse M,Nonoguchi N,Kawabata S,et al.Delayed brain radiation necrosis:pathological review and new molecular targets for treatment[J].Med Mol Morphol,2015,48(4):183~190.
[27] 赵魁,林日清,陈志国,等.依达拉奉右莰醇在放射性脑损伤中的潜在治疗价值[J].中国现代医生,2023,61(35):120~122+126.
[28] Hu RY,Liang J,Ding L,et al.Edaravone dexborneol provides neuroprotective benefits by suppressing NLRP3 inflammasome-induced microglial pyroptosis in experimental ischemic stroke[J].Int Immunopharmacol,2022,113(Pt A):109315.
[29] 肖芸,龚晓昌,谢洪辉,等.恩度治疗鼻咽癌晚期放射损伤的临床观察[J].实用癌症杂志,2019,34(3):450~452.
[30] Gonzalez J,Kumar AJ,Conrad CA,et al.Effect of bevacizumab on radiation necrosis of the brain[J].Int J Radiat Oncol Biol Phys,2007,67(2):323~326.
[31] Torcuator R,Zuniga R,Mohan YS,et al.Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis[J].J Neurooncol,2009,94(1):63~68.
[32] Levin VA,Bidaut L,Hou P,et al.Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system[J].Int J Radiat Oncol Biol Phys,2011,79(5):1487~1495.
[33] 翁维吉,钱中润,邱永明.需要手术干预的放射性脑坏死(附4例报告)[J].临床神经外科杂志,2016,13(3):217~220.
[34] Chen C,Guo Y,Chen Y,et al.The efficacy of laser interstitial thermal therapy for brain metastases with in-field recurrence following SRS:systemic review and meta-analysis[J].Int J Hyperthermia,2021,38(1):273~281.
[35] Hong CS,Beckta JM,Kundishora AJ,et al.Laser interstitial thermal therapy for treatment of cerebral radiation necrosis[J].IntJ Hyperthermia,2020,37(2):68~76. |
